From ip-health-admin@lists.essential.org  Tue May 22 11:58:22 2007
Return-Path: <ip-health-admin@lists.essential.org>
Received: from lists.essential.org (lists.essential.org [65.222.215.36])
	by flax9.uwaterloo.ca (8.12.8/8.12.5) with ESMTP id l4MFwLqD014126
	for <ktwarwic@flax9.uwaterloo.ca>; Tue, 22 May 2007 11:58:22 -0400
Received: from lists.essential.org (localhost.localdomain [127.0.0.1])
	by lists.essential.org (Postfix) with ESMTP
	id 47633B3CF; Tue, 22 May 2007 11:56:02 -0400 (EDT)
Delivered-To: ip-health@lists.essential.org
Received: from web27203.mail.ukl.yahoo.com (web27203.mail.ukl.yahoo.com [217.146.182.93])
	by lists.essential.org (Postfix) with SMTP id 44314B3AE
	for <Ip-health@lists.essential.org>; Tue, 22 May 2007 07:55:36 -0400 (EDT)
Received: (qmail 73450 invoked by uid 60001); 22 May 2007 11:55:35 -0000
DomainKey-Signature: a=rsa-sha1; q=dns; c=nofws;
  s=s1024; d=yahoo.co.uk;
  h=X-YMail-OSG:Received:X-Mailer:Date:From:Subject:To:MIME-Version:Content-Type:Message-ID;
  b=peR9882gBjw10apTf1tjH8P9kjdFw0LQJWNtVzTYEB76FLit38Rc2UUmyNAAvBLkYzXPJjslUVEEuzc5kiwwx3tFNH34wqftfnXvxoW/8kGdx+92RX0d1rRn/Kstxo7zTUbMdzkaF1EdXBl9gmXzp2u9Ur90fgxChvbkj6Bs+os=;
X-YMail-OSG: PFQgbYEVM1kw6lWCKE4RA0FMsyPdpdlSGIYEk4iARr0kkt9kw2BUQPbsdCkquprVQIa1JPXYMQ8misjxzMYKEqLkPM0pyO_2cz9gHDKFMV09f4or
Received: from [139.141.90.22] by web27203.mail.ukl.yahoo.com via HTTP; Tue, 22 May 2007 11:55:35 GMT
X-Mailer: YahooMailRC/651.23.1 YahooMailWebService/0.7.41.10
From: Spielas Ball <spielasball@yahoo.co.uk>
Subject: Re: [Ip-health] drug naming/patents/exclusivity
To: Sue Rochman <sue.rochman@earthlink.net>,
   IP-Health <Ip-health@lists.essential.org>
MIME-Version: 1.0
Message-ID: <751202.72913.qm@web27203.mail.ukl.yahoo.com>
content-transfer-encoding: 7bit
content-type: text/plain;
 charset=ascii
Sender: ip-health-admin@lists.essential.org
Errors-To: ip-health-admin@lists.essential.org
X-BeenThere: ip-health@lists.essential.org
Precedence: bulk
List-Help: <mailto:ip-health-request@lists.essential.org?subject=help>
List-Post: <mailto:ip-health@lists.essential.org>
List-Subscribe: <http://lists.essential.org/mailman/listinfo/ip-health>,
	<mailto:ip-health-request@lists.essential.org?subject=subscribe>
List-Id: Discussions of Intellectual Property and Health Care <ip-health.lists.essential.org>
List-Unsubscribe: <http://lists.essential.org/mailman/listinfo/ip-health>,
	<mailto:ip-health-request@lists.essential.org?subject=unsubscribe>
List-Archive: <http://lists.essential.org/pipermail/ip-health/>
X-Original-Date: Tue, 22 May 2007 11:55:35 +0000 (GMT)
Date: Tue, 22 May 2007 11:55:35 +0000 (GMT)

There is the example of celecoxib which is marketed as Celebrex and as Onsenal - the latter specifically for familial adenomatous polyposis.

Regards
Spielas Ball
---------
Faculty of Pharmacy
Kuwait University
spielasball[AT]yahoo.co.uk





      ___________________________________________________________
Yahoo! Mail is the world's favourite email. Don't settle for less, sign up for
your free account today http://uk.rd.yahoo.com/evt=44106/*http://uk.docs.yahoo.com/mail/winter07.html
_______________________________________________
Ip-health mailing list
Ip-health@lists.essential.org
http://lists.essential.org/mailman/listinfo/ip-health

